Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
SGLT2 inhibitor
Locations
1
United States
University of Minnesota
Minneapolis, Minnesota, United States
Start Date
April 1, 2024
Primary Completion Date
August 16, 2024
Completion Date
August 16, 2024
Last Updated
August 23, 2024
NCT05806645
NCT07472426
NCT07447791
NCT07106151
NCT07418242
NCT05879432
Lead Sponsor
University of Minnesota
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions